Passage Bio, Inc.
PASG
$7.48
-$0.065-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.86M | -63.46M | -64.77M | -68.80M | -76.57M |
| Total Depreciation and Amortization | 1.85M | 2.48M | 3.08M | 3.17M | 3.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 19.44M | 20.23M | 17.75M | 9.37M | 11.49M |
| Change in Net Operating Assets | -504.00K | -2.11M | -4.02M | -2.76M | -9.03M |
| Cash from Operations | -36.07M | -42.87M | -47.96M | -59.03M | -70.74M |
| Capital Expenditure | -34.00K | -34.00K | -34.00K | -33.00K | -17.00K |
| Sale of Property, Plant, and Equipment | 1.17M | 585.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 67.73M | 68.78M | 54.98M | 48.90M | 56.37M |
| Cash from Investing | 68.86M | 69.33M | 54.95M | 48.87M | 56.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 61.00K | 132.00K | 8.87M | 8.87M | 8.87M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 61.00K | 132.00K | 8.87M | 8.87M | 8.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 32.86M | 26.58M | 15.86M | -1.29M | -5.52M |